- The federal relief fund for small businesses just ran money, but here are the billions of dollars in grants available from the Trump administration to promote innovation
- The National Institutes of Health:
- The Biomedical Advanced Research and Development Authority:
- The National Science Foundation: Grants up to 0,000
- Department of Defense's Basic Research Office: Grants up to 0,000
- Department of Commerce's National Institute of Standards and Technology (NIST): Grants up to million
- COVID-19: Federal Update (8/25)
- Washington Insider: What We're Hearing
- Washington Insider: What We're Reading
- COVID-19 Legislative & Regulatory Trackers
The federal relief fund for small businesses just ran money, but here are the billions of dollars in grants available from the Trump administration to promote innovation
Across the corporate landscape, there are many examples of how big-name corporations are using advanced technology in the fight against the coronavirus.
Companies IBM and D-Wave are offering free, remote access to their quantum computers. Others, Cisco, are using 3D printing technology to make face shields across the globe. And hospitals that underwent digital overhauls are already employing their new tools to enhance their response capabilities.
These are examples of the kind of innovation the federal government is promoting during this outbreak — and not just from the larger players.
Across agencies the Department of Defense and the National Institutes of Health, billions of dollars of funding are available to small businesses, startups, and individual researchers to pursue more technologically advanced tools to fight the coronavirus. And these programs could come in handy as other funding avenues — the small business relief fund — run money.
The grants focus on everything from vaccine development to quantum science-based solutions that aim to change our understanding of modern scientific problems. Some of this technology may seem more science fiction at this point than grounded in reality.
“America's vibrant innovation ecosystem has always brought outside-the-box ideas and technologies to the forefront to address great challenges,” US Chief Technology Officer Michael Kratsios said in a Tuesday statement. “The Trump Administration is committed to leveraging our country's brilliant start-ups, entrepreneurs, and technologists in the fight against COVID-19.”
Read on to see the grants currently available.
The National Institutes of Health: $1.78 billion
The NIH's funding is focused in several different areas, including vaccine and test development.
Among the specific products the agency is seeking applications for are home-based diagnostic tests, wearable health monitors, and artificial intelligence-backed systems to help scan X-rays and other data sources for potential infections.
The NIH is also supporting no-contact research projects examining how effective remote stress management techniques — such as virtual yoga or hypnosis — are in helping at-risk populations coronavirus patients manage anxiety and depression.
While the NIH has adjusted its application deadline to May 1, it has also noted the need for urgency in submissions.
“This rapidly evolving situation also creates multiple challenges for conducting review, and the timeline for getting review outcomes to councils (so that funding can occur) can only be delayed so long,” the agency wrote.
The Biomedical Advanced Research and Development Authority: $1.69 billion
BARDA is the federal department tasked with developing and stockpiling medical countermeasures for bioterrorism threats.
The agency invests in private-sector efforts to research vaccines, diagnostic testing and other treatments. And it's now halting all other grants and focusing only on those that support the federal coronavirus response.
Among the areas it is seeking submissions on are diagnostic development, research into treatments that aid in lung repair, and ventilators.
BARDA, for example, expanded an ongoing, $1 billion partnership with Johnson & Johnson, as the pharmaceutical giants plans to begin human trials of a potential vaccine in September.
More than a dozen other drugmakers are also rushing to begin clinical trials.
The National Science Foundation: Grants up to $200,000
The NSF is viewed as the non-clinical counterpart to the NIH.
The $8.3 billion agency funds roughly 24% of all federal research at US academic institutions. And during the coronavirus, the agency is shifting its focus to data-driven programs that can help monitor and anticipate the outbreak.
While the NSF is encouraging researchers to capitalize on existing grant offers, it is touting a program that allows the department to quickly deploy yearlong grants up to $200,000.
The agency is also running a separate grant program to provide funding to small businesses that use AI, blockchain, and other advanced tech to help the US respond to the pandemic.
Department of Defense's Basic Research Office: Grants up to $100,000
Social media users have turned to Sir Issac Newton as inspiration during the era of social distancing.
The famed inventor used the wide shutdown of facilities during the Great Plague of London to advance much of his work on gravity, calculus, and other topics.
And the Department of Defense is no different.
Single researchers or teams of two can apply for the “Newton Award for Transformative Ideas.”
The grant encourages the development of more out-of-the-box solutions to the pandemic — including quantum science-based tools that “present disruptive ways of thinking about fundamental scientific problems.”
“The objective of this program is to generate proposals that are equally novel and pioneering. Therefore, this [grant] should be viewed as an opportunity to propose basic research that falls outside the bounds of traditional proposals,” the department's research office wrote.
Department of Commerce's National Institute of Standards and Technology (NIST): Grants up to $10 million
NIST is tasked with providing scientific and technical guidance on issues data privacy or cybersecurity that, while not required, are used by many companies as basic frameworks for their own efforts.
The new, coronavirus-specific grants from the department rely on funds included in the $2 trillion stimulus package that President Trump signed into law last month.
The department is seeking proposals on areas ranging from the development of medical countermeasures for the coronavirus to bringing more drug supply chains back to the US.
Among the examples cited by NIST are scaling up production of wearable medical detection equipment, switching production lines to advanced manufacturing techniques, and training programs to teach workers how to use the new tools.
COVID-19: Federal Update (8/25)
— CONGRESS SET TO RECONVENE IN SEPTEMBER. Both chambers have adjourned for the August district work period, and are not expected to convene for legislative business until next month.
— WHITE HOUSE TOUTS OPPORTUNITY-ZONE TAX BREAK CRITICIZED BY DEMOCRATS. The Council of Economic Advisers (CEA) published a report touting the benefits of a program encouraging investment in low-income communities.
— 2020 GOP CONVENTION ENTERS DAY TWO. Click here for details.
— CMS ISSUES BULLETIN ON MEDICAID REIMBURSEMENT STRATEGIES TO PREVENT SPREAD OF COVID-19 IN NURSING FACILITIES. The guidance outlines flexibilities that are available to increase reimbursement for nursing facilities that implement specific infection control practices.
Washington Insider: What We're Hearing
— SENATE GOP DRAFTS 'SKINNY' PANDEMIC RELIEF BILL. Republicans have drafted a slimmed-down version of their HEALS Act legislation that would address an array of COVID-19 priorities.
Provisions in the Delivering Immediate Relief to America’s Families, Schools and Small Businesses Act pertain to testing, treatment, vaccines, the postal service, small business relief, education, unemployment insurance, and liability protections.
For more on the Senate GOP's draft bill, click here to read TRP's analysis.
— PANDEMIC EXECUTIVE ORDERS. With negotiations on the next round of COVID-19 relief legislation at a standstill, President Donald Trump issued a series of executive orders on pandemic-related priorities.
The orders seek to restore the enhanced federal unemployment benefits at a rate lower than the CARES Act allocation, defer payroll taxes until early 2021, renew the moratorium on evictions, and continue deferring student loan payments and accrued interest under the CARES Act Statute.
The executive actions do not touch on any health-specific priorities such as testing and treatment, nor does it address liability-related issues — leaving employers at-risk of litigation until a compromise deal is hammered out.
Details on the orders include:
Unemployment Insurance. This order seeks to extend the pandemic unemployment assistance (PUA) established by the CARES Act, lowering the weekly bonus from $600 to $400.
The administration calls on states to front 25 percent of the cost — equivalent to $100 toward the weekly benefit — with the federal government covering the remaining 75 percent.
To fund the revamped PUA, the White House outlined hundreds of billions in federal funding that the administration plans to “reprogram” in a manner similar to the way it has diverted Pentagon funding for wall construction on the U.S.-Mexico border.
The president says he will tap into roughly $80 billion in unallocated money from the CARES Act State, Local, and Tribal Coronavirus Relief Fund, as well as more than $40 billion from the Federal Emergency Management’s (FEMA) Disaster Relief Fund, to fund these efforts.
Payroll Tax. This order directs the Treasury Department to allow employers to defer payment of employee-side Social Security payroll taxes through the end of 2020 for employees earning less than about $100,000 annually.
While the text of the EO states that the intended deferral period would start Sept. 1, President Trump suggested that it could be retroactive to Aug. 1, saying that he hopes to forgive the deferred payroll taxes and make permanent payroll tax cuts if he is reelected in November.
While the tax code does give the Treasury secretary authority to delay tax filing and collection amid presidentially-declared disasters, it remains to be seen whether employers will stop withholding payroll taxes given the risk of future liability.
Critics of this particular order have also expressed concerns about the impact this action could have on both the short and long-term solvency of the Social Security and Medicare trust funds.
Housing. This EO outlines potential policy actions that federal agencies could take to address housing evictions during the balance of the pandemic, but does not offer an explicit pause on evictions.
Specifically, the order instructs agencies to: (1) consider whether halting evictions will help stem the spread of COVID-19 across state lines; (2) identify available funds available to provide temporary financial assistance to renters and homeowners; (3) promote the ability of renters and homeowners to avoid eviction or foreclosure by encouraging and providing assistance to public housing authorities, affordable housing owners, landlords, and recipients of Federal grant funds in minimizing evictions and foreclosures; and (4) review all existing authorities and resources that may be used to prevent evictions and foreclosures for renters and homeowners. Congressional Democrats reportedly agree that the president does have the authority to address housing evictions via executive order, but are unly to be satisfied with what they would consider to be the administration’s watered-down approach in this executive action.
Student Loans. This order directs the Department of Education to take the necessary steps to continue the CARES Act policy that temporarily pauses payments and waives interest on student loans held by the Department until Dec. 31.
The EO does not, however, specifically reference student loan debt collection or counting non-payments toward public service loan forgiveness, both of which were included in the CARES Act.
Additionally, the EO does not offer coverage for federal student loan borrowers whose debt is held by private lenders or their colleges — a priority that Congressional Democrats have sought in the COVID-19 relief talks.
— HEALS Act. Senate Republicans officially introduced their opening offer proposal for the next round of COVID-19 relief legislation following days of intraparty negotiations between GOP Senators and White House officials. The legislative package was officially released as multiple pieces of legislation, with six total sections:
Click here to view TRP's side-by-side of the Senate GOP HEALS Act and the House Democratic HEROES Act.
Washington Insider: What We're Reading
The Wall Street Journal: White House Touts Opportunity-Zone Tax Break Criticized by Democrats ($)
The White House released a report touting the benefits of a program encouraging investment in low-income communities, which Democrats have criticized as a boon to affluent people. The incentive for so-called opportunity zones attracted an estimated $75 billion in capital through 2019, according to the report released Monday.
President Trump’s campaign is making the program—created in the 2017 tax law—a key part of its re-election pitch and is calling for an unspecified expansion. The opportunity-zone program is different from many prior federal initiatives in low-income communities.
It is focused on creating incentives for private investment in specific areas with relatively few restrictions rather than requiring direct benefits for people who live in the zones.
The Hill: Survey: One-fifth of Small Businesses Will Close if Conditions Don't Improve
One in every five small businesses say they will not be able to stay open if economic conditions don't improve in the next six months, and a similar number say they can only last a year.
The survey from the National Federation of Independent Business, a trade group for small businesses, found that while many businesses expected to stay afloat, the pandemic was hitting significant numbers in devastating ways.
Roll Call: Biden Retirement Proposal Would Upend Traditional 401(k) Plans
A little-noticed feature of Democratic presidential nominee Joe Biden’s tax plan would flip the incentive structure of a retirement system grounded for nearly a century on the tax deductibility of saving.
The former vice president’s “drastic” proposal, in the words of one industry lobbyist, would upend existing tax preferences for retirement saving in 401(k)-style plans.
The Investment Company Institute, which represents mutual funds, exchange-traded funds and other investment vehicles in the U.S. and abroad, has already promised opposition.
The Hill: EPA Approves Coronavirus-Killing Product — For Just One Airline
The Environmental Protection Agency (EPA) has approved what it says is the first long-lasting product to fight surface transmission of the coronavirus, but the special dispensation to use it is primarily going to one company: American Airlines. Monday’s announcement clears the way for the use of SurfaceWise2 by American Airlines in Texas, the first state to apply for an emergency exemption to use the disinfectant, which kills the virus on surfaces for up to seven days.
COVID-19 Legislative & Regulatory Trackers
— CMS ISSUES BULLETIN ON MEDICAID REIMBURSEMENT STRATEGIES TO PREVENT SPREAD OF COVID-19 IN NURSING FACILITIES. The Centers for Medicare and Medicaid Services (CMS) issued a Medicaid Informational Bulletin outlining guidance to states on flexibilities that are available to increase reimbursement for nursing facilities that implement specific infection control practices.
This includes information on the Disaster State Plan Amendments (SPA) template and describes how states may use state-directed payments to increase reimbursement to nursing facilities in managed care
— HHS ADDS HEALTH PLANS TO JUNE 2020 PLASMA DONATION GUIDANCE.
The Department of Health and Human Services (HHS) Office of Civil Rights (OCR) issued amended guidance on how the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy Rule permits covered health care providers and health plans to contact their patients and beneficiaries who have recovered from COVID-19 to inform them about how they can donate their convalescent plasma.
The guidance emphasizes that, without individuals' authorization, the providers and health plans cannot receive any payment from, or on behalf of, a plasma donation center in exchange for such communications with recovered individuals.
— FDA GRANTS EMERGENCY USE FOR CONVALESCENT PLASMA TREATMENTS. The Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
— TRUMP ADMINISTRATION INVOKES DPA FOR NURSING HOME RAPID TESTS. HHS announced that it has invoked the Defense Production Act (DPA) to secure rapid COVID-19 tests and supplies for roughly 14,000 nursing homes across the country.
— FDA ISSUES GUIDANCE ON PRODUCT INSPECTIONS DURING THE COVID-19 PUBLIC HEALTH EMERGENCY. FDA published a final guidance document outlining answers to questions about regulatory and policy issues pertaining to inspections, pending drug applications, and changes in manufacturing facilities for approved pharmaceuticals.
— TRUMP ADMINISTRATION SCALES BACK FDA REVIEW OF CERTAIN COVID-19 TESTS. HHS announced yesterday that it will allow COVID-19 tests developed by individual laboratories to be used without a review from the Food and Drug Administration (FDA)
— HHS MOVES TO EXPAND ACCESS TO COVID-19 VACCINES FOR CHILDREN. HHS issued an amendment to the Declaration under the Public Readiness and Emergency Preparedness Act (PREP Act) aimed at increasing access to the childhood vaccines.
The amendment authorizes State-licensed pharmacists to order and administer vaccines to individuals ages three through 18 years, subject to several requirements.
— FDA ISSUES RECOMMENDATIONS FOR INVESTIGATIONAL COVID-19 CONVALESCENT PLASMA. FDA has issued guidance that outlines recommendations to health care providers and investigators on the administration and study of investigational convalescent plasma collected from individuals who have recovered from COVID-19.
— UPDATED ANALYSIS OF THE PROVIDER RELIEF FUND. HHS continues to make distributions under the $175 billion provider relief fund made possible by the CARES Act and successor legislation. Click here to read TRP’s analysis of the distributions.
Recently, the agency announced $1.4 billion in new funding for children’s hospitals and an extended deadline of August 28 for Medicaid, CHIP, and dental providers to apply for relief.
Furthermore, the agency reopened applications for one of the initial tranches of funding, allowing providers who missed the first opportunity or were ineligible to seek CARES Act funds.
— TRUMP ADMINISTRATION ANNOUNCES 'WARP SPEED' COLLABORATION WITH MCKESSON ON VACCINE DISTRIBUTION. HHS and the Department of Defense (DoD) announced a new “Operation Warp Speed” collaboration with McKesson Corporation that would make the company a central distributor of future COVID-19 vaccines and related supplies.
— HHS SENDS NEW PROVIDER RELIEF FUNDS TO CHILDREN'S HOSPITALS. HHS, through the Health Resources and Services Administration (HRSA), announced $1.4 billion in provider relief funding to dozens of free-standing children’s hospitals nationwide.